Empire Life Investments’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-63,438
Closed -$1.06M 106
2022
Q1
$1.06M Sell
63,438
-940
-1% -$16.4K 0.07% 84
2021
Q4
$1.29M Hold
64,378
0.08% 85
2021
Q3
$1.17M Buy
64,378
+34,437
+115% +$790K 0.08% 83
2021
Q2
$808K Buy
+29,941
New +$838K 0.05% 90

Other funds holding CVET

Empire Life Investments's CVET Position: Q2 2022 in Review

Empire Life Investments sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2022, closing a stake of 63,438 shares — an estimated $1.06M sold.

Empire Life Investments first reported a position in CVET in Q2 2021 and held it in 4 quarters. The position peaked at $1.29M in Q4 2021. 266 funds tracked by Wall St. Rank hold CVET as of Q2 2022.

  • Empire Life Investments reported no remaining Covetrus, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Empire Life Investments sold 63,438 Covetrus, Inc. Common Stock shares in Q2 2022, an estimated $1.06M.
  • Empire Life Investments first reported a position in Covetrus, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Empire Life Investments's Covetrus, Inc. Common Stock position peaked at $1.29M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2022.

Based on Empire Life Investments's 13F filing for Q2 2022, filed 3 Aug 2022.